Annals of Oncology, 0923-7534

Journal

View graph of relations

Related Publications
  1. Paclitaxel/carboplatin/bevacizumab in non-small cell lung cancer patients induces peripheral effector CD8 T cell proliferation that could be prone for treatment with checkpoint inhibitors

    Dumoulin, D., de Goeje, P., Poncin, M., Bezemer, K., Groen, H. J. M., Smit, E. F., Dingemans, A-M. C., Kunert, A., Hendriks, R. & Aerts, J. G., Apr-2019, In : Annals of Oncology. 30, 1 p.

    Research output: Contribution to journalMeeting AbstractAcademic

  2. The effect of prophylactic cranial irradiation (PCI) for young stage III NSCLC patients: Subgroup analyses of the NVALT-11/DLCRG-02 study

    Witlox, W. J. A., Ramaekers, B., Groen, H. J. M., Dingemans, A-M. C., Praag, J., Belderbos, J., Van der Noort, V., Van Tinteren, H., Joore, M. A. & De Ruysscher, D., Apr-2019, In : Annals of Oncology. 30, p. 33-+ 2 p.

    Research output: Contribution to journalMeeting AbstractAcademic

  3. EPAC-Lung: Pooled analysis of circulating tumor cells in advanced non-small cell lung cancer

    Lindsay, C. R., Blackhall, F. H., Carmel, A., Gazzaniga, P., Groen, H. J. M., Krebs, M. G., Muinelo-Romay, L., Pantel, K., Rossi, E., Terstappen, L., Wikman, H., Soria, J-C., Farace, F. F., Renehan, A., Dive, C., Besse, B. & Michiels, S., Apr-2019, In : Annals of Oncology. 30, 1 p.

    Research output: Contribution to journalMeeting AbstractAcademic

  4. Circulating tumor cells are prognostic in SCLC, but still lack clinical application

    Tamminga, M. & Groen, H. J. M., 16-May-2019, In : Annals of Oncology. 9 p.

    Research output: Contribution to journalArticleAcademic

  5. Zr-89-labeled anti-PD-L1 CX-072 PET imaging in human xenograft and syngeneic tumors

    Giesen, D., Broer, L. N., Lub-De Hooge, M. N., Popova, I., Howng, B., Vasiljeva, O., de Vries, E. G. E. & Pool, M., Feb-2019, In : Annals of Oncology. 30, 1 p.

    Research output: Contribution to journalMeeting AbstractAcademic

View all (178) »

ID: 13479495